RSS Amplifier

Topic · collider

collider

The 35 most recent episodes and tracks on this topic, about 8.1 hours of it.

Saves to your Listen queue, to pick up on another day or another device.

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

  1. Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective and Anti-Inflammatory StrategyIDEA Collider: Innovation & Asymmetric Learning in Pharma48:51Notes
  2. The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.IDEA Collider: Innovation & Asymmetric Learning in Pharma49:53Notes
  3. The Power of the Early Narrative: Sue Wood on Strategic Biotech PositioningIDEA Collider: Innovation & Asymmetric Learning in Pharma43:22Notes
  4. The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.IDEA Collider: Innovation & Asymmetric Learning in Pharma1:02:50Notes
  5. The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO RevolutionIDEA Collider: Innovation & Asymmetric Learning in Pharma20:45Notes
  6. Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target MappingIDEA Collider: Innovation & Asymmetric Learning in Pharma34:53Notes
  7. Episode 333: Denise Frey of 4Youth LLCRochester Rising PodcastNotes
  8. Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech TurnaroundsIDEA Collider: Innovation & Asymmetric Learning in Pharma36:29Notes
  9. Episode 332: Dara Kautz of Socius Design Shop & Lifestyle BoutiqueRochester Rising PodcastNotes
  10. Building the Future of Targeted Protein Degradation Medicines with Nello MainolfiIDEA Collider: Innovation & Asymmetric Learning in Pharma41:09Notes
  11. AI & Competitive Intelligence in Pharma: Smarter Decision-Making with SAI MedPartnersIDEA Collider: Innovation & Asymmetric Learning in Pharma53:29Notes
  12. Episode 331: Ginger & Kennis Knapp of Ama La VitaRochester Rising PodcastNotes
  13. Rewriting the Future of Rare Disease: Engineered tRNA and a New Therapeutic Paradigm with Michelle WernerIDEA Collider: Innovation & Asymmetric Learning in Pharma41:27Notes
  14. sec_colliders_glisguardichechiedi_mix_session_20250523_2232SexColliders3:56Notes
  15. sexcolliders_piccolina_20220904_session_250523_2156SexColliders3:18Notes
  16. Sex Colliders - Macchinette - 11 Quando non ci seiSexColliders3:15Notes
  17. Sex Colliders - Macchinette - 13 Ragazza madreSexColliders4:39Notes
  18. Sex Colliders - Macchinette - 08 TrenoSexColliders3:21Notes
  19. Sex Colliders - Macchinette - 05 MonterreySexColliders3:12Notes
  20. Sex Colliders - Macchinette - 07 CaselliSexColliders3:24Notes
  21. Sex Colliders - Macchinette - 02 Non dovreiSexColliders1:35Notes
  22. Sex Colliders - Macchinette - 06 Chi l'ha dettoSexColliders3:36Notes
  23. PixiesSexColliders5:02Notes
  24. TonightSexColliders3:12Notes
  25. La forma del fiancoSexColliders3:09Notes
  26. ElettricaSexColliders2:59Notes
  27. TurniSexColliders3:01Notes
  28. Mare urbanoSexColliders2:50Notes
  29. Episode 330: Grassroots Growth Observations with Amanda LeightnerRochester Rising PodcastNotes
  30. Episode 329: Becky Montpetit of Rochester LocalRochester Rising PodcastNotes
  31. Episode 328: Donna Unseth of Unseth WoodworkRochester Rising PodcastNotes
  32. Episode 327: Molly AlthoffRochester Rising PodcastNotes
  33. Episode 326: Devon Hugdahl of Permanent PressRochester Rising PodcastNotes
  34. Episode 325: Carmen Tiffany of Brite Design StudioRochester Rising PodcastNotes
  35. Episode 324: Juliana Silva, Director of Startup Support at Collider FoundationRochester Rising PodcastNotes